SEI Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.6M | Sell |
129,981
-3,245
| -2% | -$1.44M | 0.06% | 368 |
|
|
2026
Q1 | $59.5M | Sell |
133,226
-230,797
| -63% | -$108M | 0.05% | 369 |
|
|
2025
Q4 | $165M | Buy |
364,023
+187,496
| +106% | +$80.8M | 0.16% | 115 |
|
|
2025
Q3 | $69.1M | Sell |
176,527
-120,876
| -41% | -$50.5M | 0.07% | 266 |
|
|
2025
Q2 | $132M | Buy |
297,403
+3,621
| +1% | +$1.67M | 0.15% | 134 |
|
|
2025
Q1 | $142M | Buy |
293,782
+18,647
| +7% | +$8.69M | 0.18% | 101 |
|
|
2024
Q4 | $111M | Buy |
275,135
+61,234
| +29% | +$28.4M | 0.14% | 139 |
|
|
2024
Q3 | $99.5M | Buy |
213,901
+1,044
| +0.5% | +$502K | 0.13% | 155 |
|
|
2024
Q2 | $99.8M | Sell |
212,857
-1,612
| -0.8% | -$700K | 0.14% | 143 |
|
|
2024
Q1 | $89.7M | Sell |
214,469
-144,885
| -40% | -$61.2M | 0.13% | 154 |
|
|
2023
Q4 | $146M | Sell |
359,354
-39,864
| -10% | -$14.7M | 0.23% | 81 |
|
|
2023
Q3 | $139M | Buy |
399,218
+297
| +0.1% | +$104K | 0.25% | 73 |
|
|
2023
Q2 | $140M | Buy |
398,921
+140,471
| +54% | +$47.3M | 0.24% | 79 |
|
|
2023
Q1 | $81.4M | Buy |
258,450
+184,117
| +248% | +$55.2M | 0.15% | 120 |
|
|
2022
Q4 | $21.5M | Sell |
74,333
-37,235
| -33% | -$11.3M | 0.05% | 433 |
|
|
2022
Q3 | $32.3M | Buy |
111,568
+23,129
| +26% | +$6.65M | 0.07% | 298 |
|
|
2022
Q2 | $25.1M | Buy |
88,439
+44,349
| +101% | +$11.9M | 0.05% | 390 |
|
|
2022
Q1 | $11.8M | Buy |
44,090
+9,761
| +28% | +$2.32M | 0.02% | 697 |
|
|
2021
Q4 | $7.48M | Sell |
34,329
-1,291
| -4% | -$251K | 0.01% | 934 |
|
|
2021
Q3 | $6.46M | Sell |
35,620
-7,796
| -18% | -$1.52M | 0.01% | 962 |
|
|
2021
Q2 | $8.74M | Sell |
43,416
-2,736
| -6% | -$572K | 0.02% | 799 |
|
|
2021
Q1 | $10.2M | Sell |
46,152
-29,939
| -39% | -$6.58M | 0.03% | 662 |
|
|
2020
Q4 | $17.9M | Sell |
76,091
-43,830
| -37% | -$10.1M | 0.05% | 395 |
|
|
2020
Q3 | $32.7M | Sell |
119,921
-2,789
| -2% | -$769K | 0.09% | 193 |
|
|
2020
Q2 | $35.6M | Sell |
122,710
-13,450
| -10% | -$3.65M | 0.11% | 168 |
|
|
2020
Q1 | $32.4M | Sell |
136,160
-11,973
| -8% | -$2.75M | 0.12% | 152 |
|
|
2019
Q4 | $32.5M | Sell |
148,133
-6,193
| -4% | -$1.25M | 0.1% | 197 |
|
|
2019
Q3 | $26.2M | Buy |
154,326
+20,690
| +15% | +$3.66M | 0.07% | 268 |
|
|
2019
Q2 | $24.5M | Sell |
133,636
-5,772
| -4% | -$1.01M | 0.08% | 256 |
|
|
2019
Q1 | $25.6M | Buy |
139,408
+4,602
| +3% | +$850K | 0.09% | 233 |
|
|
2018
Q4 | $25.5M | Buy |
134,806
+14,351
| +12% | +$2.49M | 0.09% | 226 |
|
|
2018
Q3 | $23.2M | Sell |
120,455
-11,228
| -9% | -$2M | 0.08% | 228 |
|
|
2018
Q2 | $22.4M | Buy |
131,683
+4,659
| +4% | +$722K | 0.08% | 267 |
|
|
2018
Q1 | $20.7M | Sell |
127,024
-31,375
| -20% | -$5.12M | 0.08% | 264 |
|
|
2017
Q4 | $23.7M | Buy |
158,399
+35,880
| +29% | +$5.31M | 0.08% | 270 |
|
|
2017
Q3 | $18.6M | Buy |
122,519
+25,069
| +26% | +$3.77M | 0.07% | 330 |
|
|
2017
Q2 | $12.6M | Buy |
97,450
+31,434
| +48% | +$3.78M | 0.05% | 454 |
|
|
2017
Q1 | $7.22M | Buy |
66,016
+1,817
| +3% | +$160K | 0.03% | 643 |
|
|
2016
Q4 | $4.73M | Sell |
64,199
-55,439
| -46% | -$4.51M | 0.02% | 788 |
|
|
2016
Q3 | $10.4M | Buy |
119,638
+36,970
| +45% | +$3.49M | 0.05% | 439 |
|
|
2016
Q2 | $7.11M | Buy |
82,668
+51,942
| +169% | +$4.49M | 0.04% | 534 |
|
|
2016
Q1 | $2.44M | Sell |
30,726
-97,848
| -76% | -$8.85M | 0.02% | 895 |
|
|
2015
Q4 | $16.2M | Sell |
128,574
-12,913
| -9% | -$1.56M | 0.1% | 257 |
|
|
2015
Q3 | $14.7M | Sell |
141,487
-27,265
| -16% | -$3.5M | 0.14% | 174 |
|
|
2015
Q2 | $20.8M | Buy |
168,752
+2,301
| +1% | +$290K | 0.19% | 129 |
|
|
2015
Q1 | $19.6M | Buy |
166,451
+96,806
| +139% | +$11.6M | 0.17% | 145 |
|
|
2014
Q4 | $8.28M | Buy |
+69,645
| New | +$7.84M | 0.07% | 308 |
|
Other funds holding VRTX
SEI Investments's VRTX Position: Q2 2026 in Review
SEI Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $1.44M and leaving 129,981 shares worth $64.6M. The position accounts for 0.06% of the portfolio, ranked #368.
SEI Investments first reported a position in VRTX in Q4 2014 and has held it in 47 quarters since. The position peaked at $165M in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- SEI Investments held 129,981 shares of Vertex Pharmaceuticals worth $64.6M as of Q2 2026.
- SEI Investments sold 3,245 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.44M.
- Vertex Pharmaceuticals made up 0.06% of SEI Investments's portfolio in Q2 2026, its #368 holding.
- SEI Investments first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's Vertex Pharmaceuticals position peaked at $165M in Q4 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.